(Q83281204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Glaucoma prescribing trends in Australia and New Zealand (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Stuart C Carroll

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Brent J Gaskin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ivan Goldberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Helen V Danesh-Meyer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Ophthalmology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

213-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

"Who's on first?": Considering the options for primary glaucoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Betaxolol vs timolol. A six-month double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Adverse reactions from timolol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Evaluation of timolol in chronic open-angle glaucoma. Once a day vs twice a day

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Timolol, dose response and duration of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Glaucoma clinical trials and what they mean for our patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Glaucoma surgery treatment patterns of ASCRS members--2000 survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Glaucoma laser treatment parameters and practices of ASCRS members--1999 survey. American Society of Cataract and Refractive Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

Glaucoma treatment in Australia: changing patterns of therapy 1994-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01196.X

10.1111/J.1442-9071.2006.01196.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16671900%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference